Pharmafile - Medical Communications News
It has been revealed that private hospitals being run across England and Wales will receive £52 million in tax breaks over the course of the next...
Another Opdivo failure for BMS, "highly disturbing" stats on childhood diabetes, and Trump left red-faced as his 'America first' manufacturing policy...
The prices of generic drugs have been driven lower as companies compete to undercut one another. This has led to dramatic changes in the fiercely...
Pfizer has received a bittersweet bout of news as it emerges that its drug Besponsa (inotuzumab ozogamicin) has received approval in the US, but...
It was a case of three-in-one bits of good news for AstraZeneca and MSD, after the FDA boosted the newly formed Lynparza partnership with an expanded...
Newcastle upon Tyne Hospital’s Chief Executive, Leonard Fenwick, has been sacked from his position after a disciplinary panel adjudged he had...
The FDA has announced that it has been forced to recall a range of liquid pharmaceutical and dietary supplement products due a possible bacterial...
Japanese pharma giant Takeda has announced that it is to partner up with US-based Shattuck Labs in a collaboration to develop checkpoint fusion...
The number of active clinical trials in the cancer space has reached more than 1,000 and rising, outstripping the number of patients needed to take...
A report from the Royal College of Paediatrics and Child Health (RCPCH) has highlighted a “hugely disturbing” rise in cases of type 2 diabetes in...
